More biosimilars reach the market in efforts to improve access and cut costs

被引：0

|

作者：

Abraham, Jame

机构：

来源：

JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY | 2018年 / 16卷 / 04期

关键词：

D O I：

10.12788/jcso.0417

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

收藏

页码：E181 / E184

页数：4

相关论文

共 50 条

[21] Improve pump performance and cut energy costs
Hollywood, Paula
HYDROCARBON PROCESSING, 2007, 86 (01): : 17 - 17
[22] CHLORINE ANALYZERS CUT COSTS, IMPROVE PERFORMANCE
CLARK, K
INTECH, 1988, 35 (05) : 39 - 42
[23] Norske skog looks to cut more costs
2002, Paperloop (17):
[24] Biosimilars in the USA: Will New Efforts to Spur Approvals and Access Spur Uptake and Cost Savings?
Mehr, Stanton R.
Brook, Richard A.
PHARMACEUTICAL MEDICINE, 2019, 33 (01) : 1 - 8
[25] Biosimilars in the USA: Will New Efforts to Spur Approvals and Access Spur Uptake and Cost Savings?
Stanton R. Mehr
Richard A. Brook
Pharmaceutical Medicine, 2019, 33 : 1 - 8
[26] MARKET ACCESS BARRIERS FOR BIOSIMILARS IN SPAIN AND GERMANY: EPOETIN ALFA EXAMPLE
Hurtado, P.
Vieta, A.
Espinos, B.
Badia, X.
VALUE IN HEALTH, 2011, 14 (07) : A336 - A336
[27] What role for real-world evidence in market access of biosimilars?
Simoens, Steven
Lockhart, Catherine M.
Courmier, Delphine F.
FRONTIERS IN PHARMACOLOGY, 2025, 16
[28] FDA's efforts to improve access to agency records
Shroff, AP
Sheehan, SM
FOOD AND DRUG LAW JOURNAL, 1998, 53 (02): : 321 - 326
[29] The need for more primary care physicians to contain costs and improve access: Myths versus realities
Stimmel, B
MOUNT SINAI JOURNAL OF MEDICINE, 1996, 63 (01): : 49 - 59
[30] Cut costs not corners to access engineering and technical information
Troup, Hilary
e.nz magazine, 2001, 2 (02): : 50 - 52

← 1 2 3 4 5 →